EthelCesarmanMD

Pathology • New York, NY

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Pathology & Laboratory Medicine, Weill Cornell Medical College

Join to view full profile

Dr. Cesarman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cesarman's full profile

Already have an account?

Office
525 E 68th St
# 69
New York, NY 10065
Phone+1 646-253-2808

Fax+1 212-746-3856

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
Autonomous Metropolitan University XochimilcoClass of 1981

Certifications & Licensure

NY State Medical License 1991 - 2025
American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2001

Publications & Presentations

PubMed

T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.
Lucy S Britto, Deepali Balasubramani, Sona Desai, Phunterion Phillips, Neev Trehan
Advanced Healthcare Materials. 2025-02-01
Exome sequencing reveals a sparse genomic landscape in Kaposi sarcoma.
Warren Phipps, Bhavneet Bhinder, Andrea Towlerton, Peter Mooka, James Kafeero
Molecular Cancer Research. 2025-01-30
Automated detection of Kaposi sarcoma-associated herpesvirus infected cells in immunohistochemical images of skin biopsies.
Iftak Hussain, Juan Boza, Robert Lukande, Racheal Ayanga, Aggrey Semeere
Research Square. 2024-08-17

Abstracts/Posters

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome
Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Press Mentions

Weill Cornell Medicine Awarded NCI Grant for EBV-Related Lymphoma ResearchFebruary 23rd, 2023
Portable Diagnostic Device Helps African Physicians Diagnose CancerAugust 24th, 2022
TINY Cancer Detection Device Proves Effective in Uganda TestingSeptember 12th, 2018

Grant Support

Weill Cornell Initiative for Maximizing Student DevelopmentWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETECORNELL UNIVERSITY2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
Role of novel onco-histone mutations in B-cell malignanciesWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
Weill Cornell Initiative for Maximizing Student DevelopmentWEILL MEDICAL COLL OF CORNELL UNIV2019–2025